IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding IN8BIO, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 28 | 12 | −16 |
| SharesConverted for a 1-for-30 split | 722.6K | 875.5K | +152.9K (+21.2%) |
| Value | $3.60M | $1.83M | −$1.77M (−49.2%) |
New holders (1)
Institutions that held IN8BIO, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 82,430 | $172.3K | 0.17% |
Sold out (17)
Institutions that held IN8BIO, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Sigma Planning Corp | 700,680 | $116.3K |
| Stonegate Investment Group, LLC | 180,000 | $29.9K |
| Northern Trust Corp | 93,420 | $15.5K |
| State Street Corp | 88,746 | $14.7K |
| XTX Topco Ltd | 69,708 | $11.6K |
| Chicago Partners Investment Group LLC | 69,301 | $11.4K |
| Two Sigma Securities, LLC | 34,279 | $5.69K |
| Overbrook Management Corp | 33,756 | $5.60K |
| Citadel Advisors LLC | 29,450 | $4.89K |
| Susquehanna International Group, LLP | 24,812 | $4.12K |
| Virtu Financial LLC | 15,110 | $3.00K |
| Capital Investment Advisory Services, LLC | 17,605 | $2.92K |
| LPL Financial LLC | 11,350 | $1.88K |
| HighTower Advisors, LLC | 10,000 | $1.66K |
| Westside Investment Management, Inc. | 2,000 | $332 |
| SBI Securities Co., Ltd. | 1,007 | $167 |
| JPMorgan Chase & Co | 102 | $17 |